Glypican 3 as target therapy to prevent cell migration and proliferation in rhabdomyosarcoma

Related articles

1. Multicellular model of temozolomide resistance in glioblastoma reveals phenotypic shifts in drug response and migratory potential

   This article has 6 authors:

   1. Victoria A Kriuchkovskaia
   2. Ela K Eames
   3. Sydney A McKee
   4. Paul J Hergenrother
   5. Rebecca B Riggins
   6. Brendan A.C. Harley

2. The Role of the Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 In Breast Cancer Pathophysiology

   This article has 7 authors:

   1. Lena Habenicht
   2. Nourhan Hassan
   3. Nancy Adriana Espinoza-Sanchez
   4. Balázs Györffy
   5. Lars C. Hanker
   6. Burkhard Greve
   7. Martin Götte

3. Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids

   This article has 19 authors:

   1. Emily E. Seiden
   2. Spencer M. Richardson
   3. Leah A. Everitt
   4. Gabrielle J. Knafler
   5. Gavin P. Kinsella
   6. Alyssa L. Walker
   7. Venetia A. Whiteside
   8. James D. Buschbach
   9. Deep A. Gandhi
   10. M. Reza Saadatzadeh
   11. L. Daniel Wurtz
   12. Patrick J. Getty
   13. Sheldon L. Padgett
   14. Rance M. Gamblin
   15. Michael O. Childress
   16. Christopher M. Fulkerson
   17. Karen E. Pollok
   18. Christopher D. Collier
   19. Edward M. Greenfield